KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Halozyme Therapeutics (HALO) Tax Rate (2016 - 2025)

Halozyme Therapeutics (HALO) has disclosed Tax Rate for 10 consecutive years, with 40.4% as the latest value for Q4 2025.

  • Quarterly Tax Rate fell 6352.0% to 40.4% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 32.11% through Dec 2025, up 1182.0% year-over-year, with the annual reading at 32.13% for FY2025, 1184.0% up from the prior year.
  • Tax Rate for Q4 2025 was 40.4% at Halozyme Therapeutics, down from 19.96% in the prior quarter.
  • The five-year high for Tax Rate was 24.41% in Q2 2022, with the low at 192.27% in Q3 2021.
  • Average Tax Rate over 5 years is 2.1%, with a median of 18.85% recorded in 2022.
  • The sharpest move saw Tax Rate plummeted -19244bps in 2021, then soared 20865bps in 2022.
  • Over 5 years, Tax Rate stood at 21.82% in 2021, then skyrocketed by 185bps to 18.49% in 2022, then dropped by -16bps to 15.6% in 2023, then surged by 48bps to 23.12% in 2024, then tumbled by -275bps to 40.4% in 2025.
  • According to Business Quant data, Tax Rate over the past three periods came in at 40.4%, 19.96%, and 19.41% for Q4 2025, Q3 2025, and Q2 2025 respectively.